Medindia LOGIN REGISTER
Medindia
Advertisement

Immune Response to Influenza is Balanced by IL-27, Reducing lung damage

by Himabindu Venkatakrishnan on May 9, 2014 at 1:03 PM
 Immune Response to Influenza is Balanced by IL-27, Reducing lung damage

A strong immune response is elicited by highly pathogenic influenza that can lead to uncontrolled inflammation in the lung and potentially fatal lung injury. A study published on May 8th in PLOS Pathogens demonstrates the importance of IL-27 for the control of immunopathology—damage to the lung tissue caused by the immune system—and the therapeutic potential of well-timed IL-27 application to treat life-threatening inflammation during lung infection.

Alf Hamann, from Deutsches Rheuma-Forschungszentrum and Charité Universitätsmedizin Berlin, Germany, and colleagues, did a comprehensive analysis of IL-27 function in mice infected with a highly pathogenic influenza strain. They found that IL-27 levels in infected lungs follow, with some delay, the level of virus: they peak as viral levels are starting to decline and come down when immunopathology has resolved. This is compatible with a role for IL-27 in dampening uncontrolled inflammation at later stages of the infection, while initially allowing for a rapid immune defense.

Advertisement

When the researchers examined mice with disrupted IL-27 function, they found that they were more likely than normal mice likely to die when infected with the virus, and that they died as a consequence of rampant lung inflammation. This was associated with a stronger immune response and stronger immunopathology. Thus, IL-27 plays an important role in limiting destructive inflammation during the advanced stages of infection.

Having discovered the crucial role of IL-27 in regulating immunopathology, the researchers wondered whether this could be exploited for therapeutic purposes. To test the potential of IL-27 treatment, they administered recombinant IL-27 (rIL-27, that is, IL-27 produced by biotechnology) to normal mice at different times after virus infection.
Advertisement

When they matched the natural course of IL-27 (treatment starting at day 5 after virus infection), they found that fewer mice died, that they lost less weight, and recovered quicker than those without treatment. In contrast, mice treated with IL-27 early (starting at the day of virus infection) were doing poorly and did not recover from the infection. Although their lungs showed less extensive damage, they were not able to control overall virus levels. This shows the importance of timing, with IL-27 treatment being beneficial only during later stages of infection but harmful when given too early.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Respiratory Disease News

Child Pneumonia Spike: Massachusetts Marks Second U.S. State
Massachusetts, now the second U.S. state grappling with a child pneumonia surge, faces a concerning outbreak in pediatric respiratory cases.
Annual Flu Vaccine: Crucial in Preventing Severe Flu Complications
Over 1 in 4 high-risk US adults (28%) not planning flu vaccination despite susceptibility to complications.
China Pneumonia Outbreak Not Linked to New Virus
The ongoing pneumonia outbreak impacting young children in China is not linked to a newly identified virus.
Pneumonia Vaccine Found Effective in Macaques
A recently developed pneumococcal vaccination was proven to be successful in the trials involving macaque monkeys.
AI-aided Home Stethoscope Monitors Asthma
Using the auscultatory sounds of asthmatic kids under age five, StethoMe, an AI-based home stethoscope, was able to accurately diagnose asthma exacerbation.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Immune Response to Influenza is Balanced by IL-27, Reducing lung damage Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests